[1] GHARAEE-KERMANI M,DENHOLM E M,PHAN S H. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors[J]. J Biol Chem,1996,271(30):17779-17784.[2] TANG N,ZHAO Y,FENG R,et al. Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts[J]. J Cell Mol Med,2014,18(1):156-169.[3] CONG C,MAO L,ZHANG Y,et al. Regulation of silicosis formation by lysophosphatidic acid and its receptors[J]. Exp Lung Res,2014,40(7):317-326.[4] ZHAO C,HUI W,FERNANDES M,et al. Lysophosphatidic acid-induced IL-8 secretion involves MSK1 and MSK2 mediated activation of CREB1 in human fibroblast-like synoviocytes[J]. Biochem Pharmacol,2014,90(1):62-72.[5] STODDARD N C,CHUN J. Promising pharmacological directions in the world of lysophosphatidic acid signaling[J]. Biomol Ther (Seoul),2015,23(1):1-11.[6] KONTNY E,ZIOLKOWSKA M,MASLINSKI W. Production of pro-inflammatory cytokines in human monocytes:not a cascade but the dependence on protein kinase C pathway[J]. Immunol Lett,1999,67(3):263-267.[7] WANG C Y,DENG Y T,HUANG S Y,et al. Epigallocatechin-3-gallate inhibits lysophosphatidic acid-stimulated connective tissue growth factor via JNK and Smad3 suppression in human gingival fibroblasts[J]. J Formos Med Assoc,2014,112(1):50-55.[8] JEON E S,KIM J H,RYU H,et al. Lysophosphatidic acid activates TGFBIp expression in human corneal fibroblasts through a TGF-beta1-dependent pathway[J]. Cell Signal, 2012,24(6):1241-1250.[9] 袁超,许铭炎,陈耿臻,等. PKC介导凝血酶诱导人肺成纤维细胞单核细胞趋化蛋白-1的表达[J]. 南方医科大学学报,2012,32(9):1250-1254.[10] DENG X,XU M,YUAN C,et al. Transcriptional regulation of increased CCL2 expression in pulmonary fibrosis involves nuclear factor-kappaB and activator protein-1[J]. Int J Biochem Cell Biol,2013,45(7):1366-1376.[11] BUDD D C,QIAN Y. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis[J]. Future Med Chem,2013,5(16):1935-1952.[12] STORTELERS C,KERKHOVEN R,MOOLENAAR W H,et al. Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profiling[J]. BMC Genomics,2008, 9(387):1-15.[13] GAN X,WANG J,WANG C,et al. PRR5L degradation promotes mTORC2-mediated PKC-delta phosphorylation and cell migration downstream of Gα12[J]. Nat Cell Biol,2012, 14(7):686-696.[14] ALCORN J F,VANDER VELDEN J,BROWN A L,et al. c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis[J]. Am J Respir Cell Mol Biol,2009,40(4):422-432.[15] YU J,OK S H,KIM W H,et al. Dexmedetomidine-induced contraction in the isolated endothelium-denuded rat aorta involves PKC-delta-mediated JNK phosphorylation[J]. Int J Med Sci,2015,12(9):727-736.[16] KONTNY E,ZIOLKOWSKA M,MASLINSKI W. Production of pro-inflammatory cytokines in human monocytes:not a cascade but the dependence on protein kinase C pathway[J]. Immunol Lett,1999,67(3):263-267.[17] MESSOUSSI A,FENEYROLLES C,BROS A,et al. Recent progress in the design,study,and development of c-Jun N-terminal kinase inhibitors as anticancer agents[J]. Chem Biol,2014,21(11):1433. |